Charming Medical vs Mangoceuticals
MCTA and MGRX side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How MCTA and MGRX compare
Charming Medical grew revenue faster over the last twelve months (−22.7% versus −38.9% for Mangoceuticals).
Charming Medical keeps more of each dollar of sales as profit, with a net margin of −0.47% compared with −4791% at Mangoceuticals.
Mangoceuticals scores higher on the StockData Score (7 against 3 for Charming Medical), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | MCTA | MGRX |
|---|---|---|
| Size and price | ||
| Market cap | – | $3.3M |
| Share price | $29.35 | $0.155 |
| Change, 1 year | 33.3% | −91.2% |
| Beta (5Y) | 0.85 | −1.27 |
| Employees | 29 | – |
| StockData Score | ||
| Total score | 3 | 7 (better) |
| Valuation score | 0 | 1 (better) |
| Growth score | 0 | 1 (better) |
| Performance score | 1 | 1 |
| Health score | 2 | 4 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | – | 10.6× |
| P/B | – | 0.3× |
| Growth | ||
| Revenue growth (TTM) | −22.7% (better) | −38.9% |
| Net income growth (TTM) | −102% | – |
| EPS growth (TTM) | −100% | – |
| Profitability | ||
| Gross margin | 99.3% (better) | 54.4% |
| Operating margin | −0.61% (better) | −3829% |
| Net margin | −0.47% (better) | −4791% |
| FCF margin | −32.4% | – |
| Return on equity | −0.87% (better) | −95.1% |
| Return on invested capital | −13.7% (better) | −60.7% |
| Financial health | ||
| Debt / equity | 0.04 (better) | 0.00 |
| Interest coverage | −1.9× | – |
| Current ratio | 1.89 (better) | 0.18 |
| Altman Z-score | – | −6.15 |
| Piotroski F-score | 2 | 3 (better) |
| Dividends and buybacks | ||
| Shareholder yield | – | 0.00% |
| Ownership | ||
| Held by institutions | 0.24% | 5.6% |
| Held by insiders | 71.9% | 57.8% |
| Insider net buying, 12 months | – | −$21.2K |
| Short interest, % of float | 11.5% | 0.59% |
Go deeper
- MCTA stock overview
- MCTA income statement
- MCTA valuation and score
- MGRX stock overview
- MGRX income statement
- MGRX valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.